Company ProfilePremium

NAOS Small Cap Opportunities Company Limited

Company Profile Analysis

Ticker: NSC.AX

ESOMAR 23 Corporate BadgeISO Certifications Badge
NAOS Small Cap Opportunities Company Limited - Company showcase

Year Founded & Workforce

2004

NAOS Small Cap Opportunities Company Limited logo

NAOS Small Cap Opportunities Company Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

NAOS Small Cap Opportunities Company Limited Overview

FieldInput list (supplied)Verified current positionNote
Legal nameNAOS Small Cap Opportunities Company LimitedNAOS Small Cap Opportunities Company LimitedConfirmed [AR26]
CountryAustraliaAustralia (registered and domiciled)Confirmed [AR26]
ExchangeAustralian Securities ExchangeASXConfirmed
TickerNSC.AXASX: NSC (Yahoo-style: NSC.AX)Confirmed
ISINJP3670800006AU000000NSC4 [AGG – TradingView]The input ISIN is wrong. The "JP" prefix denotes a Japanese security. The Australian ISIN is AU000000NSC4.
Websitecontango.com.au/.../contango-microcap-limited/www.naos.com.auThe input URL is obsolete. It refers to the pre-2017 manager (Contango) and the former name (Contango MicroCap Limited).

Entity profiled: NAOS Small Cap Opportunities Company Limited (ACN 107 617 381; ABN 47 107 617 381). It is listed on the ASX under ticker NSC, and its website is naos.com.au. It is the same legal entity formerly named Contango MicroCap Limited (ASX: CTN).

Snapshot table

ItemDetailSource
Legal nameNAOS Small Cap Opportunities Company Limited[AR26]
Former nameContango MicroCap Limited (ASX: CTN)[AGG]
Founded / constitutedConstituted 14 January 2004; commenced operations 25 March 2004[AR26] Notes
Listing dateNot confirmed from primary filings. TradingView gives an IPO date of 28 Jan 2004, which conflicts with the operations start date of 25 Mar 2004 in [AR26]. Treat as early 2004.[AGG] vs [AR26]
Incorporation jurisdictionAustralia (public company under the Corporations Act 2001)[AR26]
Registered office / HQLevel 34, 25 Martin Place, Sydney NSW 2000[AR26]
Exchange / tickerASX: NSC[AR26]
Other listed securitiesNone currently. Unlisted wholesale notes are on issue (face value $13,243,000). Formerly listed: Contango Convertible Notes (ASX: NSCG), redeemed Dec 2019.[NTA-Jul26]; ASX 28 Nov 2019
ISINAU000000NSC4[AGG]
CUSIPNot applicable / not publicly disclosed—
Fiscal year end30 June[AR26]
EmployeesNil. The Company has no executive employees; investment management, administration and company secretarial functions are outsourced to the Investment Manager.[AR26] Remuneration Report
Employee trend (3 years)FY24: 0; FY25: 0; FY26: 0[AR26]
Investment ManagerNAOS Asset Management Pty Ltd (ACN 107 624 126; AFSL 273529). Renamed from NAOS Asset Management Limited effective 7 Aug 2026. Appointed 20 Oct 2017.[AR26]
AuditorDeloitte Touche Tohmatsu (lead partner: Jonathon Corbett)[AR26]
Shares on issue132,001,294 (30 Jun 2026 and 31 Jul 2026)[AR26]; [NTA-Jul26]
Market capitalisation~$41.6m at 31 Jul 2026 ($0.315/share); ~$42m at ~$0.32/share in recent trading[NTA-Jul26]; [AGG – InvestSMART]
Pre-tax NTA per share$0.2809 (30 Jun 2026); $0.28 (31 Jul 2026)[AR26]; [NTA-Jul26]
Post-tax NTA per share$0.37 (30 Jun 2026); $0.41 (31 Jul 2026)[AR26]; [NTA-Jul26]
BenchmarkS&P/ASX Small Ordinaries Accumulation Index (XSOAI)[AR26]
FeesManagement fee 1.15% p.a.; performance fee 20% of outperformance, with prior under-performance to be recouped[NTA-Jul26]

NSC is a small (~$42m market capitalisation, ~$50m gross portfolio) closed-ended LIC. It provides concentrated, long-horizon exposure to Australian and New Zealand emerging industrial companies and excludes resources. It is managed by NAOS Asset Management, a Sydney boutique that is majority-owned by its staff and directors, and it sits between the NAOS Emerging Opportunities (NCC) and NAOS Ex-50 (NAC) strategies by investee size. The portfolio holds only eight positions, has a weighted average investee market cap of ~$116m, and has a weighted holding period of ~70 months. Fewer than 1% of its holdings by weight are benchmark constituents. The vehicle's shareholder proposition rests on a high quarterly dividend (5.0 cps p.a., partially franked) and an active buyback. Since NAOS took over in December 2017, the investment portfolio has materially underperformed its benchmark: -3.27% p.a. versus +5.65% p.a. to 30 June 2026. The vehicle also carries meaningful note-funded leverage against a shrinking asset base.


Company's own description (paraphrased from [AR26])

NSC states that its objective has three parts:

  • provide long-term concentrated exposure to Australian and New Zealand emerging companies;

  • deliver a sustainable stream of dividends franked to the maximum extent possible;

  • achieve long-term performance above the S&P/ASX Small Ordinaries Accumulation Index.

The Directors' Report describes the principal activity as investing primarily in a concentrated portfolio of listed equities, excluding resource companies. The monthly update adds that NSC's investees are generally slightly larger than those held by sister LIC NCC [NTA-Jul26].

Business model

DimensionCharacterisation
Legal / economic formClosed-ended, ASX-listed investment company. Capital is permanent (no redemption risk), and shareholders exit by selling on-market.
Revenue modelNo product, service, subscription or licensing revenue. "Revenue" is investment income: dividends, interest, and realised plus unrealised gains/losses on financial assets at fair value through profit or loss. It can be, and in FY24–FY26 was, negative.
Cost modelExternal management fee (1.15% p.a.), potential performance fee (20%), interest on unsecured notes, transaction costs, listing/registry/custody, audit/legal, and directors' fees.
Funding modelEquity (132.0m shares) plus $13.24m face value of unlisted unsecured wholesale notes [NTA-Jul26].
Shareholder return levers(1) Portfolio return; (2) quarterly dividends paid from a profits reserve; (3) on-market buybacks at a discount to NTA; (4) DRP satisfied on-market to avoid dilution.
Value-chain positionCapital allocator and engaged minority shareholder in small industrial companies, sometimes with board representation or influence over board appointments ([AR26] "Investing with NAOS").
Customer typesShareholders (predominantly retail/SMSF investors in NAOS's ~5,500-investor base across its vehicles) and wholesale noteholders.
End-markets (indirect, via investees)Building products distribution (BRI), medical devices / sleep apnoea (SOM), truck and trailer parts (MXI), NZ freight and logistics (MOV), school uniforms and sportswear (SBZ), engineering and construction for the water, defence and fuel sectors (SND).

Independent characterisation

NSC is effectively a leveraged, eight-stock, deep-value/turnaround small-cap portfolio. Its outcomes depend on a handful of illiquid micro- and small-caps.

Three features dominate its economics:

Extreme concentration: Eight holdings. Single-name events can move NAV 20–30% in a month: February 2025 was -30.14% after BSA lost its NBN Co contract [NTA-Jul26]; [AGM25].

Structural leverage: Notes of $13.24m sit against a ~$50m portfolio, roughly 26% gross gearing. They equal ~36% of pre-tax NAV of ~$37.1m (132.0m shares × $0.2809).

A dividend policy that exceeds earnings: The 5.0 cps annual dividend equals ~18% of the 30 Jun 2026 pre-tax NTA. It is funded from a profits reserve (7.9 cps at 30 Jun 2026) rather than from recurring income.

Shareholder returns have therefore diverged sharply from portfolio returns. FY26 total shareholder return was +33.14% while the portfolio returned -9.86%, because the share price moved from a 26.64% discount to a 15.70% premium to pre-tax NTA [AR26].

Strategy

Stated strategy (themes from [AR26], paraphrased)

Concentration: Zero to twenty holdings ("quality over quantity").

Long-term perspective: Many core investments are held for three or more years.

Management alignment: Back proven, owner-aligned management teams.

Ignore the index: More than 90% of the portfolio sits outside ASX indices.

Circle of competence: Avoid businesses dominated by interest rates or commodity prices.

Liquidity premium: Exploit the illiquidity of small caps, enabled by the closed-end structure.

Constructive engagement: Contribute growth capital, help on capital management and strategy, and on occasion take board seats.

ESG integration and negative screens: Excludes tobacco, gambling, nuclear/uranium, controversial weapons, coal mining, oil and gas production, and animal cruelty.

The investment universe funnel runs from 2,203 ASX-listed companies to 312 in the NAOS universe, to 41–90 on the active watchlist, to 0–20 holdings [AR26].

Initiatives in the last 24 months

InitiativeDateDetailStatus
Debt refinancing and deleveragingFY25$32.17m of notes repaid; $13.11m new notes issuedCompleted
Ongoing buybackFY25–FY262.07m shares (FY25) and 0.91m shares (FY26) cancelled; buyback notifications dated 17 and 22 Apr 2026Ongoing
Non-dilutive DRPOngoingDRP satisfied on-market while shares trade at a discountOngoing
Quarterly dividend maintenanceFY25–FY261.25 cps per quarter maintained despite losses; franking reducedOngoing
Shareholder engagementOngoingQuarterly webinars, quarterly reports, monthly NTA, roadshows (Oct–Nov 2026)Ongoing
Manager restructure7 Aug 2026NAOS Asset Management Limited became a Pty LtdCompleted
Portfolio repositioningFY26SomnoMed added as a newer core holding (featured in the Q3 FY26 report)Completed

Medium-term targets and guidance

NSC gives no financial guidance. The Board anticipates "a significantly stronger FY27", citing positive post-year-end updates from holdings [AR26]. The manager identified FY27 catalysts at MOV, BRI, SOM and SND (see §22). There are no quantified NAV, return or dividend targets beyond the dividend objective.

Products & Services

As an LIC, NSC's "products" are (a) its own listed shares and associated shareholder programs, and (b) its investment portfolio. Both are catalogued below.

Securities and shareholder programs

OfferingDescriptionTarget holderLatest statusPricing / terms
NSC ordinary sharesASX-listed exposure to the concentrated portfolioRetail, SMSF, advised investors132,001,294 on issueMarket price ~$0.32
Quarterly dividends1.25 cps per quarter (5.0 cps p.a.)All shareholdersMaintained through FY26; FY26 dividends 50% frankedFunded from profits reserve (7.9 cps at 30 Jun 2026)
Dividend Reinvestment Plan (DRP)Reinvest dividends without brokerage; satisfied on-market when shares trade below NTAShareholdersActive; FY26 DRP $914k all bought on-marketNo discount disclosed
On-market buybackAccretive purchases below NTA—FY26: 906,890 shares for $290,893; notices dated 17 Apr 2026 and 22 Apr 2026Discretionary
Unlisted unsecured notesWholesale debt fundingWholesale investorsFace value $13,243,000implied cash cost ~8.6% (FY26 cash interest $1.142m ÷ $13.24m)

Investment portfolio, holding by holding (30 Jun / 31 Jul 2026)

HoldingTickerDescription (as disclosed by NAOS)Key datapointsNAOS thesis / catalystsSource
Big River IndustriesASX: BRIManufacturer and distributor of value-added timber and building materials in Australia and NZ25 sites; >9,000 trading accounts; ~570 staff; ~65% residential exposure; revenue ~$500mDec 2025 acquisition of Johns Building Supplies (WA) for $17m; CTL (Aust) built a ~19.9% stake; strategic review with Greenstone Partners; FY27 guidance of double-digit EBITDA growth[AR26]
SomnoMedASX: SOMGlobal leader in oral appliances for obstructive sleep apnoea, operating in 28 countries; >1m devices delivered since 2004FY25 revenue ~$112m; FY26 preliminary revenue $114–115m (below $119–126m guidance); EBITDA mid-range of $10–12m guidance; ~61% gross margin; Philippines manufacturingMargin expansion via automation; market share gains; Rest Assure sensor-enabled device (FDA clearance for compliance monitoring; efficacy approval pending); new Virtus product[AR26]
MaxiPARTSASX: MXICommercial truck and trailer aftermarket parts>162,000 parts; 30 sites; >30 years in operationNot detailed in AR26[AR26]; [NTA-Jul26]
MOVe Logistics GroupASX/NZX: MOVOne of NZ's largest freight and logistics providers>750 staff; >3,500 customers; 40 branches; revenue ~NZ$300m; market cap ~NZ$25mReturn to positive normalised EBT in FY26 (confirmed July 2026); exit of onerous warehousing leases; target 3–5% NPAT margin[AR26]
Schoolblazer LtdASX: SBZGlobal schoolwear and sportswear platform (Schoolblazer UK, Trutex, Mountcastle)Renamed Feb 2026; ~1,000 contracted schools; ~A$200m FY27 revenue target; board and executives own ~25%E-commerce expansion (MySchool.Shop); sourcing and technology integration[AR26]
Saunders InternationalASX: SNDEngineering and construction (core plus water and defence expansion)Returned to profit in 2H FY26 under a new CEOLarger water and defence contracts; data centre and defence tailwinds[AR26]
BSA Limited (status unclear)ASX: BSATelco and infrastructure servicesLost NBN Co tender Feb 2025; share price fell ~90%Whether still held is not disclosed[AGM25]
Two further holdings—————

The portfolio has eight holdings, a 0.50% cash weighting, a weighted average investee market cap of $116.4m, and a weighted holding period of 70 months [NTA-Jul26]. Individual position weights are not publicly disclosed. The six named holdings are below; the remaining two are not publicly disclosed.

Sister strategies managed by NAOS (context, not NSC products)

VehicleMandateBenchmarkSource
NAOS Emerging Opportunities (ASX: NCC)Smaller emerging companies; NAOS's first LIC, 2013S&P/ASX Small Ordinaries Accumulation[Q4FY26]
NAOS Ex-50 Opportunities (ASX: NAC)Industrials outside the ASX 50S&P/ASX 300 Industrials Accumulation[Q4FY26]
NAOS Private Opportunities FundWholesale private/public—[AR26]

Financial Narrative

Data provenance. FY25–FY26 line items come from audited statements in [AR26]. FY22–FY26 net result, equity, post-tax NTA and share price come from the audited 5-year table in [AR26]. FY22–FY24 income and operating cash flow come from [AGG] and should be treated as indicative.

Income statement

Expense discipline. Total operating expenses fell 20% (3,905k to 3,133k). Interest fell 22% after the FY25 debt paydown, and management fees fell 24% as assets shrank. The management expense ratio rose from 2.1% (FY23) to 2.4% (FY24) to 3.5% (FY25) [AGG – InvestSMART], because fixed costs were spread over a shrinking base.

Balance sheet

Notes

  • FY24 borrowings of 32,171k are inferred from the FY25 note repayment of $32.171m, an analyst inference. Contemporaneous disclosures show the 2019 issue at $27m, so the 32,171k likely includes later top-ups.

  • InvestSMART reports FY24 equity of $95.9m and FY23 equity of $135.7m, which conflicts with the audited 5-year table ($79.2m and $112.2m). The audited [AR26] figures are used.

  • The DTA of $12.2m equals ~9.2 cps. This is why post-tax NTA ($0.37) exceeds pre-tax NTA ($0.28). The value of post-tax NTA therefore depends on future taxable profits being generated to use the tax losses.

Cash flow

Notes. FY22–FY24 operating cash flow is from [AGG]. For an LIC, operating cash flow includes net investment sales and purchases, so it reflects portfolio realisation rather than recurring earnings. Recurring cash yield is thin. In FY26, dividends received ($1.78m) did not cover interest paid ($1.14m) plus other cash costs ($1.31m), let alone $6.6m of dividends. The shortfall was met by net portfolio sales of $7.7m.

Ratios

Notes

  • Payout ratios for FY23–FY25 are from [AGG].

  • For FY2025, notes face value to gross portfolio uses the carrying value of $12.7m against $63.6m.

  • ROIC, net debt/EBITDA, asset turnover and cash conversion cycle are not meaningful for an LIC with negative EBITDA and no working-capital cycle.

Trend commentary

  1. Capital base erosion. Equity fell from $120.4m (FY22) to $49.2m (FY26), a 59% decline. The causes are cumulative losses of ~$57m over FY22–FY26 (–19.8, +2.6, –24.3, –9.1, –6.6) plus ~$33m of dividends paid out at 5 cps p.a. Post-tax NTA per share fell 56%, from $0.84 to $0.37.

  2. Inflection that did not hold. The portfolio rebounded ~+24% from March to June 2025 [AGM25] and +9.69% in H1 FY26 [HY26], suggesting a recovery. Each month from February to June 2026 was then negative. The board attributed this to "share price reductions in a small number of large holdings" against a backdrop of RBA rate increases (+0.75% to 4.35%) and higher oil prices [AR26].

  3. Deleveraging, then re-gearing by attrition. The FY25 refinancing cut debt by ~$19m. Because assets kept shrinking, notes as a share of the portfolio rose again, from ~20% to ~26.5%.

  4. Dividend sustainability. The profits reserve stood at 7.9 cps against a 5.0 cps annual payout, about 1.6 years of cover without new realised profits. Franking fell from 100% (FY22–FY24) to 50% on FY26 declarations, signalling depleted franking credits.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Income Statement and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Total investment income (AUD K)

-27,3433,410-30,063-5,634-3,567

Management fees (AUD K)

———957732

Performance fees (AUD K)

———00

Interest expense (AUD K)

———1,4951,172

Transaction costs (AUD K)

———468371

Listing custody registry fees (AUD K)

———233175

Legal and professional fees (AUD K)

———7191

Amortisation (AUD K)

———153113

Directors remuneration (AUD K)

85106110110110

Other expenses (AUD K)

———418369

Total expenses (AUD K)

———3,9053,133

Pre-tax result (AUD K)

———-9,539-6,700

Income tax benefit (AUD K)

———468103

Net profit after tax (AUD K)

-19,7882,610-24,282-9,071-6,597

EBITDA proxy pre-tax plus interest plus amortisation (AUD K)

———-7,891-5,415

EPS basic and diluted (AUD cents)

—1.9-17.9-6.74-5.00

Dividends declared per share (AUD cents)

5.005.005.005.005.00

Franking of dividends paid in year (%)

1001001007537.5

Balance Sheet and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Financial assets at fair value (AUD K)

———63,61150,033

Cash and equivalents (AUD K)

——360203305

Deferred tax asset (AUD K)

———12,00012,169

Total assets (AUD K)

———75,94562,697

Borrowings unsecured notes carrying value (AUD K)

——32,17112,74812,861

Short-term debt (AUD K)

———00

Net debt (AUD K)

——31,81112,54512,556

Total liabilities (AUD K)

———13,21113,456

Shareholders equity (AUD K)

120,401112,20379,15962,73449,241

Profits reserve (AUD K)

——16,76510,02510,405

Goodwill and intangibles (AUD K)

00000

Working capital (AUD K)

———63,48249,933

Post-tax NTA per share (AUD)

0.840.810.590.470.37

Pre-tax NTA per share (AUD)

——0.500.38170.2809

Dividends & Capital Returns

MetricFY2022FY2023FY2024FY2025FY2026

Net operating cash flow (AUD K)

10,94810,6688,80326,6946,998

Purchases of investments (AUD K)

———33,95642,849

Proceeds from sale of investments (AUD K)

———61,10050,582

Dividends received (AUD K)

———2,6271,781

Interest paid to noteholders (AUD K)

———1,4081,142

Capex (AUD K)

00000

Free cash flow (AUD K)

10,94810,6688,80326,6946,998

Dividends paid in cash net of DRP (AUD K)

———5,7425,691

DRP shares bought on-market (AUD K)

———998914

Share buybacks (AUD K)

———614291

Notes repaid (AUD K)

———32,1710

Notes issued (AUD K)

———13,1100

Margin Analysis (%) and Financial Ratios (x)

MetricFY2022FY2023FY2024FY2025FY2026

ROE on average equity (%)

-16.42.2-25.4-12.8-11.8

ROA on closing assets (%)

———-11.9-10.5

Current ratio (x)

———138.184.9

Debt to equity (%)

——40.620.326.1

Notes face value to gross portfolio (%)

———20.026.5

Interest coverage pre-tax plus interest over interest (x)

———-5.4-4.7

Dividend payout of NPAT (%)

—269-28-74-100

Investment portfolio return (%)

-14.722.62-22.93-9.08-9.86

Benchmark XSOAI return (%)

———12.268.11

Results by Region

MetricFY2024FY2025FY2026

Australia and NZ investment income (AUD K)

-30,063-5,634-3,567

Share Price and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Share price at 30 June (AUD)

0.730.680.440.280.325

Post-tax NTA per share (AUD)

0.840.810.590.470.37

Price to post-tax NTA (x)

0.870.840.750.600.88

Price to pre-tax NTA (x)

——0.880.731.16

Dividend per share (AUD cents)

5.005.005.005.005.00

Dividend yield at year-end price (%)

6.87.411.417.915.4

Market capitalisation (AUD Mn)

—93.859.437.242.9

Share buyback (AUD K)

———614291

Change by Period

PeriodChangeBasis

1 year (to 31 Jul 2026)

~+8.6% (price only)

[AGG – Investing.com]

FY26 total shareholder return

+33.14% (+35.41% including franking)

[AR26]

3 years (30 Jun 2023 to 30 Jun 2026)

-52.2% (price only; 0.68 to 0.325)

Calculated from [AR26]

4 years (30 Jun 2022 to 30 Jun 2026)

-55.5% (price only)

Calculated from [AR26]

52-week range

$0.285–$0.45

[AGG – Investing.com, Jul 2026]

Recent price

~$0.32

[AGG – InvestSMART]

Valuation Snapshot

MultipleValueComment

Market cap

~$42.2m

132.0m × $0.32

Enterprise value

~$55.1m

Plus $13.24m notes less ~$0.3m cash

Price / pre-tax NTA (Jul 2026)

~1.14x (~14% premium)

Unusual for a sub-scale LIC

Price / post-tax NTA (Jul 2026: $0.41)

~0.78x

Flattered by the DTA

Trailing dividend yield

~15.6% (unfranked basis)

5 cps / 32c

P/E, EV/EBITDA, EV/Sales

Not meaningful (negative earnings and revenue)

—

Analyst consensus

None. No broker coverage identified.

—

Credit ratings (Moody's / S&P / Fitch)

Not rated. The 2019 notes were explicitly unrated; the current notes are presumed unrated.

ASX 2019

Per-Share Data

MetricFY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026

Dividends declared (AUD cents)

5.504.004.005.005.005.005.005.005.00

Capital Instruments

InstrumentFace valueCouponMaturityStatus

Contango Convertible Notes (NSCG)

$26.5m

—

31 Mar 2020

Redeemed ~17 Dec 2019

Unlisted wholesale notes (2019)

$27m (repaid balance $32.17m in FY25)

4.95% p.a., subject to step-up

3 Dec 2024

Repaid FY25

Unlisted unsecured notes (current)

$13,243,000

——

Outstanding; non-current at 30 Jun 2026, so the maturity is after Jun 2027

Analyst Conclusions

Management guidance

  • No quantitative guidance is given. The Board expects "a significantly stronger FY27" [AR26], citing post-balance-date updates from investees.

  • The manager named four FY27 catalysts:

    1. MOV moving to sustainable profitability (3–5% NPAT margin target);

    2. BRI delivering a step-change in earnings, plus M&A optionality (JBS acquisition, CTL stake, strategic review);

    3. SomnoMed expanding margins and progressing Rest Assure (commercial clarity expected by end CY26);

    4. SND winning larger water and defence contracts.

  • There are no consensus forecasts.

Bull case

  1. Deep value in the remaining book. On the manager's estimates, MOV trades at ~2.7x prospective earnings at a 3% margin and BRI at ~10x hoped-for FY27 NPATA. With MOV now profitable and SND back in profit, the manager argues earnings recovery could re-rate an eight-stock book quickly. FY21 (+58.40%) shows the portfolio's upside convexity.

  2. Corporate activity. CTL's ~19.9% blocking stake in BRI and the Greenstone strategic review create takeover or merger optionality at a core holding.

  3. Cheap embedded tax shield and aligned insiders. Tax losses (DTA of $12.2m) shelter future gains. Directors and the CIO keep buying shares, and buybacks plus on-market DRP purchases prevent dilution. July 2026 already showed +3.83 percentage points of outperformance.

Bear case

  1. The dividend is consuming capital. A 5 cps dividend on a 28c pre-tax NTA means a ~18% annual distribution. The profits reserve covers only ~1.6 years. Absent strong realised gains, NSC must cut the dividend, cut franking further, or keep returning capital, any of which could hit a share price now trading at a premium.

  2. Leverage on a shrinking base. Notes of $13.24m equal ~36% of pre-tax NAV. Another -20% portfolio year would push gearing near 50% of NAV and could raise refinancing or covenant issues; the terms are not public.

  3. Track record and scale. Performance is -8.92% p.a. relative to the benchmark since inception and -24.09% p.a. relative over three years. With ~$50m of assets, fixed costs above 3% of NAV and a premium that may not persist, a strategic outcome (merger with NCC or NAC, wind-up, or restructuring) becomes increasingly plausible. That would be a catalyst that could cut either way.

Key catalysts and monitorables (next 12 months)

TimingMonitorable
MonthlyNTA updates: pre-tax NTA trajectory versus the 28c base; premium/discount
~Oct 2026 / Jan 2027 / Apr 2027Quarterly dividend declarations: rate (1.25 cps) and franking level
12 Nov 2026AGM: director re-elections; any capital management or strategic commentary
End CY26SomnoMed Rest Assure go-to-market and FDA efficacy update
H1 FY27BRI strategic review outcome; CTL intentions
Feb 2027NSC H1 FY27 results; profits reserve balance; DTA treatment
OngoingNotes maturity and refinancing disclosure; buyback activity
MacroRBA path; New Zealand recovery; residential construction cycle

Analyst verdict

NSC is a small, leveraged, high-conviction LIC whose shareholder outcomes are driven by three things: a handful of illiquid industrial turnarounds, a generous dividend, and the market's swings between pessimism and optimism about NAOS. The underlying record is poor. Since NAOS took over in December 2017, the portfolio has lost a quarter of its value while the benchmark gained 60%. Five-year returns are double-digit negative per annum. Equity has fallen from $120m to $49m in four years.

Yet FY26 showed how disconnected the share price can be. Shareholders earned 33% while the portfolio lost 10%, because a 27% discount became a 16% premium. That premium is the crux of the current assessment. At ~1.14x pre-tax NTA, the market is paying above liquidation value for a vehicle with ~26% gearing on its portfolio, a profits reserve worth only about 1.6 years of dividends, declining franking, and a cost base that is heavy for its size. The premium likely reflects yield-seeking retail demand and confidence in the manager's FY27 recovery thesis. Some of that thesis has evidence: MOV is profitable, SND is profitable, and BRI has strategic optionality.

There are credible positives. Insiders keep buying and never sold. Capital management avoids dilution. The FY25 refinancing materially reduced interest burden. If two or three core holdings re-rate, an eight-stock leveraged book could recover NAV quickly. July 2026's outperformance is an early, though single-month, signal.

On balance, the risk/reward for a new investor is skewed unfavourably at a premium to NTA. The dividend is likely unsustainable at the current rate without portfolio gains, and the notes' terms and maturity are undisclosed in the sources reviewed. NSC is best viewed as a speculative recovery play on NAOS's stock-picking. Its key tests in FY27 are NAV growth, retention of the dividend, and clarity on refinancing and the vehicle's long-term scale. Monitoring, rather than conviction, is warranted.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleAppointedIndependenceBackground and other rolesEducationFY26 total remuneration (AUD)NSC shares at 30 Jun 2026

David Rickards OAM

Independent Chair (Chair since 10 Nov 2022)

28 Feb 2018

Independent

Ex-Macquarie executive director, global head of equities research and strategy (1989–2013); Barra International; co-founder of Sefa; former treasurer of Bush Heritage Australia; director of NAC

MBA (UQ); BE Civil and BE Structural (Sydney); BSc

35,157495,606

Sarah Williams

Independent Director

25 Aug 2022

Independent

Ex-Macquarie executive director and head of IT (asset management, investment banking, leasing); JP Morgan; PwC London; chair of NAC and NCC

Hons Engineering Physics (Loughborough)

25,11387,790

Trevor Carroll

Independent Director (Chair Oct 2017–Nov 2022)

27 Mar 2017

Independent

Ex-ANZ CEO of Electrolux Home Products; past director of The Good Guys, Fusion Retail Brands and Crane Group; Ai Group National President 2006–08

BCom (Canterbury)

25,113229,089

Warwick Evans

Non-Independent Director

20 Oct 2017

Not independent (Chair of the Investment Manager)

Ex-MD of Macquarie Equities (1991–2001); founding Chair and CEO of the Newcastle Stock Exchange; Chair of the Australian Stockbrokers Association; County NatWest

BCom Economics (UNSW)

25,113961,212

Sebastian Evans

Non-Independent Director; joint Company Secretary

20 Oct 2017

Not independent (CIO and MD of NAOS)

CIO and MD of NAOS since 2010; director of NAC and NCC

MAppFin; BCom; GradDip Mgmt (AGSM); Dip Fin Services

Nil (paid by the Investment Manager)

1,781,123

Executive Leadership Team

NameRoleJoined NAOSPrior rolesEducation

Sebastian Evans

CIO and Managing Director

2010 (CIO/MD)

—

As above

Robert Miller

Portfolio Manager across all NAOS LICs

Sep 2009 (PM since Nov 2014)

—

BBus (UTS); MAppFin

Jared Tilley

Senior Investment Analyst

Apr 2021

Contact Asset Management; Colonial First State (9 years)

BCom (Notre Dame); CFA

Tom Pearce

Associate Analyst

May 2025

—

BCom/BAdvStudies (Sydney)

Rajiv Sharma

Chief Business Officer; Company Secretary (since 12 Mar 2021)

2017

Magellan Financial Group; Custom Fleet (Element); Johnson Winter & Slattery; Clayton Utz

LLB (Hons I), BBus, GDLP (UTS)

Mohit Kabra

Chief Financial Officer

2025

Deloitte, 17+ years across three continents

BCom (Hons) (Delhi); CPA (Colorado); AICPA; ICAI

Angela Zammit

Marketing and Communications Manager

May 2020

SAI Global; American Express; Citibank

BComms (Canberra)

Governance Overview

ItemPosition

Chair / CEO separation

NSC has no CEO. The Chair (Rickards) is independent of the Investment Manager.

Board independence

3 of 5 independent (60%)

Committees

Not detailed in the retrieved filings; the Corporate Governance Statement is on naos.com.au/corporate-governance.

Governance framework

Adopts the ASX Corporate Governance Principles and Recommendations [AR26]

Key related-party arrangement

Investment management agreement with NAOS (1.15% management fee; 20% performance fee with high-water-mark-style recoupment). Two directors are affiliated with NAOS.

Cross-directorships

All five NSC directors also sit on at least one other NAOS LIC board (NAC and/or NCC)

Major Shareholders

HolderShares% of issued capitalSource / date

Directors (aggregate)

3,554,820

~2.69

[AR26], 30 Jun 2026

NAOS Asset Management Ltd

1,580,4001.19

[AGG – Motley Fool]; date not stated

Directors and NAOS staff (aggregate)

~3.2m

—

[AGM25], Nov 2025 (likely an earlier snapshot)

Institutional ownership

Not publicly disclosed in retrieved sources. The register is predominantly retail; NAOS cites ~5,500 investors across its vehicles.

——

Competitive Landscape

Key Competitors

CompetitorTickerCategoryRelative positioning vs NSCComparative data

NAOS Emerging Opportunities

NCC

Sister LIC (smaller investees)

Same manager and board overlap; potential consolidation candidate

—

NAOS Ex-50 Opportunities

NAC

Sister LIC (ex-ASX 50 industrials)

Same manager

Gross portfolio $47.5m (31 Jul 2026) [AGG – NAC NTA]

WAM Microcap

WMI

Micro-cap LIC (Wilson Asset Management)

Much larger, diversified, strong brand

—

Spheria Emerging Companies

SEC

Small/micro-cap LIC

Diversified value approach

—

Ophir High Conviction

OPH

Small/mid-cap LIT

Growth-oriented

—

Thorney Opportunities

TOP

Concentrated / activist small-cap LIC

Similarly concentrated and activist

—

Glennon Small Companies

GC1

Small-cap LIC

Similar size

—

Sandon Capital Investments

SNC

Activist LIC

Engagement-led like NAOS

—

Ryder Capital

RYD

Concentrated small/mid-cap LIC

High concentration

—

ECP Emerging Growth (formerly Barrick Street)

ECP

Small/mid-cap LIC

Quality growth

—

Small-cap ETFs (e.g., S&P/ASX Small Ords trackers)

Various

Passive

Low cost; benchmark-like returns

Benchmark +8.11% in FY26

Peer Comparison FY2026

MetricNSCXSOAI benchmarkNAC

FY26 return (%)

-9.868.11—

3-year return p.a. to Jun 2026 (%)

-14.209.89—

5-year return p.a. to Jun 2026 (%)

-11.182.98—

Return p.a. since Dec 2017 inception (%)

-3.275.65—

Gross portfolio, Jul 2026 (AUD Mn)

50.6—47.5

Management fee (%)

1.15——

Recent Developments

--

Company Snapshot

2004

Founded

Sydney, Australia

Headquarters

SWOT Analysis

Strengths

  • Permanent capital suits illiquid holdings: Closed-end structure has no redemption risk; weighted holding period is 70 months [NTA-Jul26]
  • Strong insider alignment, still increasing: Directors hold 3.55m shares, +11% in FY26, with no sales in two years [AR26]
  • Shareholder-friendly capital management: Non-dilutive DRP; 37.22m shares bought back since Apr 2019 [HY26]; FY26 buyback accretive
  • Lower cost of carry after deleveraging: Interest expense fell from $1.495m to $1.172m; notes cut from ~$32m to $13.2m [AR26]
  • Tax losses support post-tax NTA: $12.2m DTA (~9.2 cps), with losses still available [AR26]
  • Experienced independent board: Chair ex-global head of equities research at Macquarie; 100% FY26 attendance for three directors [AR26]
  • Clean audit with no non-audit services: Deloitte unmodified opinion; KAM limited to standard valuation and existence [AR26]

Weaknesses

  • Persistent underperformance: 5-year -11.18% p.a. vs +2.98% p.a.; since inception -24.80% vs +60.25% [AR26]
  • NAV erosion: Post-tax NTA fell from $0.84 (FY22) to $0.37 (FY26); equity from $120.4m to $49.2m [AR26]
  • Dividend exceeds earnings power: 5.0 cps ≈ 18% of pre-tax NTA; profits reserve 7.9 cps ≈ 1.6 years of cover [AR26]
  • Falling franking: Franking of dividends paid fell from 100% (FY24) to 75% (FY25) to 37.5% (FY26) [AR26]
  • Extreme concentration: 8 holdings; February 2025 -30.14% from one stock (BSA) [NTA-Jul26]; [AGM25]
  • Sub-scale cost base: MER 3.5% in FY25 [AGG]; fixed listing and admin costs on a ~$50m base
  • Thin recurring income: FY26 dividends received $1.78m versus $6.6m of dividends paid [AR26]

Opportunities

  • Earnings turnarounds at core holdings: MOV positive normalised EBT in FY26; SND profitable in 2H FY26 [AR26]
  • Corporate activity at BRI: CTL at ~19.9%; Greenstone strategic review [AR26]
  • SomnoMed product pipeline: Rest Assure FDA pathway; Virtus launch; ~61% gross margin with automation upside [AR26]
  • Valuation gap claimed by the manager: MOV implied P/E ~2.7x at a 3% NPAT margin; BRI ~10x on the hoped-for FY27 NPATA [AR26] (manager estimates)
  • Infrastructure tailwinds: Data-centre and defence build-out benefits SND [AR26]
  • Early FY27 outperformance: July 2026 +0.66% vs benchmark -3.17% [NTA-Jul26]

Threats

  • Macro: higher-for-longer rates: RBA raised 0.75% to 4.35% in FY26 [AR26]
  • Re-widening discount from a premium: Shares moved from a 26.64% discount to a 15.70% premium in FY26; reversal risk is high [AR26]
  • Execution risk at investees: SOM missed revenue guidance ($114–115m vs $119–126m) [AR26]
  • GLP-1 disruption to sleep apnoea: Zepbound approved for OSA; the manager views it as market-expanding, but the risk is debated [AR26]
  • Structural pressure on sub-scale LICs: ETF competition; the sector has seen consolidation (general context)

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
16 Apr 2025FY25 Q3 dividend of 1.25 cps declared unfranked [AR26]First unfranked dividend; signals depleted franking
Mar–Jun 2025Portfolio rebounds ~+24% cumulatively after the BSA shock [AGM25]Partial NAV recovery
4 Jun 2025FY25 Q3 dividend paid ($1.682m) [AR26]—
30 Jun 2025FY25 close: pre-tax NTA $0.3817; share price $0.28 (26.64% discount) [AR26]Deepest discount of the period
21 Aug 2025FY25 results: loss $9.07m; final dividend 1.25 cps (unfranked) [AR26]; [AGM25]—
Jul–Oct 2025Four consecutive positive months (+4.33%, +3.37%, +4.07%, +4.29%) [NTA-Jul26]Momentum recovery
30 Sep 2025FY25 final dividend paid ($1.651m) [AR26]—
Late Sep 2025CTL (Aust) begins accumulating BRI shares [AR26]Strategic holder in a core investee
22 Oct 2025FY26 Q1 dividend of 1.25 cps (50% franked) declared [AR26]Partial franking restored
11 Nov 2025AGM; Chair cites 36.32m shares bought back since inception [AGM25]—
Nov 2025Portfolio -7.24% in the month [NTA-Jul26]Volatility
28 Nov 2025Q1 dividend paid ($1.650m) [AR26]—
Dec 2025BRI completes the $17m JBS acquisition [AR26]Core investee scale-up in WA
23 Dec 2025NAOS-associated entities provide a $250k loan facility (12% p.a.) to Wingara AG [AGG – ShareCafe via Techleap]Manager-level activity; NSC involvement not disclosed
30 Dec 2025CTL discloses a 5.39% BRI substantial holding [AR26]—
3 Feb 2026Q2 FY26 investor update webinar ASX/Webull—
Feb 2026Investee renamed Schoolblazer Ltd (ASX: SBZ) [AR26]Focus on school uniforms
19 Feb 2026H1 FY26: profit $6.98m (vs -$1.43m PCP); pre-tax NTA $0.40; half-year TSR 42.82%; Q2 dividend 1.25 cps (50% franked) [HY26]High point of FY26
Feb–Jun 2026Five consecutive negative months (-3.44%, -4.75%, -4.01%, -3.22%, -1.92%) [NTA-Jul26]; [AR26]NAV decline; "SaaSpocalypse", RBA hikes, Middle East conflict
10 Apr 2026Q2 dividend paid ($1.652m) [AR26]—
17 Apr 2026Notification of buyback lodged [AGG – InvestSMART]Capital management
22 Apr 2026Q3 FY26 dividend 1.25 cps (50% franked) declared; buyback notice updated [AR26]; [AGG]—
23 Apr 2026Q3 FY26 quarterly investment report (SomnoMed featured) [AGG]; [AR26]—
30 Apr 2026Q3 FY26 investor update webinar ASX/Webull—
May 2026CTL lifts its BRI stake to ~19.9% through a series of notices [AR26]Potential corporate activity at BRI
1 Jun 2026Dividend/distribution update lodged [AGG]Administrative
4 Jun 2026Q3 dividend paid ($1.652m) [AR26]—
30 Jun 2026FY26 close: pre-tax NTA $0.2809; price $0.325 (15.70% premium) [AR26]Discount reversed to premium
July 2026MOV confirms positive normalised EBT for FY26 [AR26]Turnaround milestone
14 Jul 2026June NTA update [AGG]—
24 Jul 2026NAOS Quarterly Investment Report Q4 FY26 [AGG]—
4 Aug 2026Q4 FY26 investor update: Q4 -8.89% vs benchmark +3.32% [Q4FY26]—
7 Aug 2026Investment Manager becomes NAOS Asset Management Pty Ltd [AR26]Corporate form change at the manager
12 Aug 2026July NTA: pre-tax $0.28; July return +0.66% vs benchmark -3.17% [NTA-Jul26]Early FY27 outperformance
21 Aug 2026FY26 results; $4.90m DTA write-down; final dividend 1.25 cps (50% franked); Annual Report re-lodged with the signed audit report [AR26]; [MR26]Key annual disclosure; minor administrative error
Aug 2026SomnoMed preliminary FY26 revenue $114–115m, below guidance [AR26]Negative for a core holding
10 / 30 Sep 2026Final dividend ex-date / payment date [AR26]—
8 Oct 2026 onwardsNAOS investor roadshow begins (Perth) [AR26]—
Pending (~mid/late Oct 2026)FY27 Q1 dividend declaration and September NTA update expected, by analogy with 22 Oct 2025 —Not yet verified
12 Nov 2026 (scheduled)2026 AGM [AR26]Director elections; nominations closed 17 Sep 2026

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

1 chart
Results by Region: Australia and NZ investment income rose from AUD -30.1 Mn in FY2024 to AUD -3.6 Mn in FY2026.
NAOS Small Cap Opportunities Company Limited — Results by Region
Series (AUD Mn)FY2024FY2025FY2026
Australia and NZ investment income-30.1-5.6-3.6

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. NSC 2026 Annual Report and Appendix 4E (updated version, 21 Aug 2026) (investorpa.com)
  2. NSC FY26 Results & Dividend Declaration media release (21 Aug 2026) (investorpa.com)
  3. NSC Monthly NTA & Portfolio Update, 31 Jul 2026 (bulletin.webull.com)
  4. NSC Monthly NTA & Portfolio Update, 30 Jun 2026 (bulletin.webull.com)
  5. NSC 2025 AGM Chair's Address (11 Nov 2025) (bulletin.webull.com)
  6. NSC Half-Year results summary (19 Feb 2026), InvestSMART (investsmart.com.au)
  7. NSC Q2 FY26 Investor Update (3 Feb 2026) (bulletin.webull.com)
  8. NSC Q3 FY26 Investor Update (30 Apr 2026) (bulletin.webull.com)
  9. Kalkine Media, Q4 FY26 Investor Update summary (4 Aug 2026) (kalkinemedia.com)
  10. ShareCafe, FY26 re-lodgement summary (sharecafe.com.au)
  11. InvestSMART NSC announcements list (investsmart.com.au)
  12. InvestSMART NSC financials (aggregator) (investsmart.com.au)
  13. ASX announcement, NSC $27m notes bookbuild (28 Nov 2019) (announcements.asx.com.au)
  14. Gilbert + Tobin deal note (NSC notes due 3 Dec 2024) (gtlaw.com.au)
  15. ShareCafe / Bell Potter LIC update (Dec 2019 refinancing) (sharecafe.com.au)
  16. TradingView NSC profile (ISIN AU000000NSC4) (in.tradingview.com)
  17. Stoxray NSC historical financials (aggregator) (stoxray.com)
  18. Investing.com NSC quote (price, 52-week range) (vn.investing.com)
  19. Motley Fool AU NSC page (NAOS AM holding) (fool.com.au)
  20. Kalkine, Contango MicroCap report (Mar 2017) (kalkine.com.au)
  21. NAOS Ex-50 (NAC) NTA update, 31 Jul 2026 (bulletin.webull.com)
  22. Wingara AG / NAOS loan facility (Dec 2025) (finder.techleap.nl)
  23. NSC FY22 Annual Report (ASX) (announcements.asx.com.au)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.